Literature DB >> 2124678

Genomic sequence of IGLV1S2, a human immunoglobulin variable lambda gene belonging to subgroup I.

F Bernard1, P Chuchana, J P Frippiat, L Buluwela, M P Lefranc.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2124678      PMCID： PMC332785          DOI： 10.1093/nar/18.23.7139

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN： 0305-1048            Impact factor:   16.971


× No keyword cloud information.
  5 in total

1.  First nucleotide sequence of a human immunoglobulin variable lambda gene belonging to subgroup II.

Authors:  F Brockly; D Alexandre; P Chuchana; S Huck; G Lefranc; M P Lefranc
Journal:  Nucleic Acids Res       Date:  1989-05-25       Impact factor: 16.971

2.  First genomic sequence of a human Ig variable lambda gene belonging to subgroup I. Functional genes, pseudogenes and vestigial sequences are interspersed in the IGLV locus.

Authors:  D Alexandre; P Chuchana; F Brockly; A Blancher; G Lefranc; M P Lefranc
Journal:  Nucleic Acids Res       Date:  1989-05-25       Impact factor: 16.971

3.  Definition of the human immunoglobulin variable lambda (IGLV) gene subgroups.

Authors:  P Chuchana; A Blancher; F Brockly; D Alexandre; G Lefranc; M P Lefranc
Journal:  Eur J Immunol       Date:  1990-06       Impact factor: 5.532

4.  Amino acid sequence of the (lambda) light chain of a human myeloma immunoglobulin (IgG New).

Authors:  B L Chen; R J Poljak
Journal:  Biochemistry       Date:  1974-03-12       Impact factor: 3.162

5.  The use of chromosomal translocations to study human immunoglobulin gene organization: mapping DH segments within 35 kb of the C mu gene and identification of a new DH locus.

Authors:  L Buluwela; D G Albertson; P Sherrington; P H Rabbitts; N Spurr; T H Rabbitts
Journal:  EMBO J       Date:  1988-07       Impact factor: 11.598
  5 in total
  9 in total

1.  Germline variable region gene segment derivation of human monoclonal anti-Rh(D) antibodies. Evidence for affinity maturation by somatic hypermutation and repertoire shift.

Authors:  J M Bye; C Carter; Y Cui; B D Gorick; S Songsivilai; G Winter; N C Hughes-Jones; J D Marks
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

Review 2.  Structural and functional properties of human lambda-light-chain variable-region subgroups.

Authors:  A Solomon; D T Weiss
Journal:  Clin Diagn Lab Immunol       Date:  1995-07

3.  Conservation of sequence in recombination signal sequence spacers.

Authors:  D A Ramsden; K Baetz; G E Wu
Journal:  Nucleic Acids Res       Date:  1994-05-25       Impact factor: 16.971

4.  Haplotypes of the human immunoglobulin lambda IGLV7S1 and IGLV1S1 genes defined by restriction-site polymorphism and insertion/deletion of a 6-kb DNA fragment.

Authors:  P Chuchana; J P Frippiat; A Blancher; G Lefranc; M P Lefranc
Journal:  Am J Hum Genet       Date:  1993-08       Impact factor: 11.025

5.  Mapping of the human lambda immunoglobulin variable gene subgroup 1.

Authors:  H E McDermid; B S Emanuel
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

6.  Repertoire cloning of lupus anti-DNA autoantibodies.

Authors:  P Roben; S M Barbas; L Sandoval; J M Lecerf; B D Stollar; A Solomon; G J Silverman
Journal:  J Clin Invest       Date:  1996-12-15       Impact factor: 14.808

7.  Characterization of a lymphoblastoid line deleted for lambda immunglobulin genes.

Authors:  C A Hough; B N White; J J Holden
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

8.  Analysis of variable region genes encoding anti-Sm and anti-cardiolipin antibodies from a systemic lupus erythematosus patient.

Authors:  C Demaison; C T Ravirajan; D A Isenberg; M Zouali
Journal:  Immunology       Date:  1995-11       Impact factor: 7.397

9.  Human anti-self antibodies with high specificity from phage display libraries.

Authors:  A D Griffiths; M Malmqvist; J D Marks; J M Bye; M J Embleton; J McCafferty; M Baier; K P Holliger; B D Gorick; N C Hughes-Jones
Journal:  EMBO J       Date:  1993-02       Impact factor: 11.598
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.